A Second Open-Label Extension of a Double-Blind, Parallel, Phase IV Study to Assess the Efficacy and Safety of Adjunctive Lovaza® (Formerly Known as Omacor®) Therapy in Hypertriglyceridemic Subjects Treated With Antara™
PHASE4
This was a 24-month, open-label extension study that followed an 8-week dou...
Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma
PHASE2
This phase II trial studies how well obinutuzumab with or without umbralisi...
Therapeutic Efficacy of Cutaneous Application of Postbiotic N-(1-carbamoyl-2-phenyl-ethyl) Butyramide (FBA) in Pediatric Subjects Affected by Atopic Dermatitis
NA
Atopic dermatitis (AD) is a chronic, multifactorial inflammatory skin disea...
Status
Completed
Location
Department of Traslational Medical Science - University of Naples Federico II
Evaluation of Efficacy and Safety of Omacor (Omega-3-acid Ethyl Esters) as Add-on Therapy in Hypertriglyceridemic Subjects Treated With Antara (Fenofibrate) Followed by an 8-week Extension
PHASE4
The purpose of OM5/LOV111859 was to evaluate efficacy and safety of Omacor ...